SCHEMBL12775465

SCHEMBL12775465

C=C1C=CC(C(C)(C)O)CC1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
CES2 O00748 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31473482 0.83
SCHEMBL1648671 0.76 NFKB1 (0.34) LMNACES2
SCHEMBL12132320 0.63
Beta-Phellandrene SCHEMBL1306441 0.63 MET (0.31)
Beta-Phellandrene SCHEMBL17629433 0.63 MET (0.31)
Beta-Phellandrene SCHEMBL154149 0.63 MET (0.31)
SCHEMBL9534440 0.61
SCHEMBL23268474 0.60
SCHEMBL15171405 0.60
SCHEMBL10779826 0.58 LMNA (0.47) LMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2314580-A1 Method for producing synthetic cannabinoids The Health Concept GmbH (DE) 2011-04-27 EP disclosed
US-20090214446-A1 CYCLODEXTRIN INCLUSION COMPLEXES AND METHODS OF PREPARING SAME CARGILL, INCORPORATED (US) 2009-08-27 US disclosed